Inhibition of fucosylation in human invasive ductal carcinoma reduces E‐selectin ligand expression, cell proliferation, and ERK 1/2 and p38 MAPK activation

Author:

Carrascal Mylène A.12,Silva Mariana234,Ramalho José S.2,Pen Cláudia5,Martins Manuela5,Pascoal Carlota1,Amaral Constança1,Serrano Isabel6,Oliveira Maria José78,Sackstein Robert34,Videira Paula A.129ORCID

Affiliation:

1. UCIBIO Departamento Ciências da Vida Faculdade de Ciências e Tecnologia Universidade Nova de Lisboa Portugal

2. CEDOC Chronic Diseases Research Center NOVA Medical School/Faculdade de Ciências Médicas Universidade Nova de Lisboa Portugal

3. Departments of Dermatology and Medicine Brigham & Women's Hospital Boston MA USA

4. Harvard Medical School Program of Excellence in Glycosciences Boston MA USA

5. Centro Hospitalar de Lisboa Central EPE – Serviço de Anatomia Patológica Lisbon Portugal

6. Hospital de Cascais Portugal

7. New Therapies Group INEB‐Institute for Biomedical Engineering Porto Portugal

8. Instituto de Investigação e Inovação em Saúde Universidade do Porto Portugal

9. CDG & Allies – PPAIN Congenital Disorders of Glycosylation Professionals and Patient Associations International Network Caparica Portugal

Funder

Pfizer

Fundação para a Ciência e a Tecnologia

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3